1,418 results on '"Santulli, Gaetano"'
Search Results
102. Sympathetic Nervous System Signaling in Heart Failure and Cardiac Aging
103. The Adrenergic System in Cardiovascular Metabolism and Aging
104. miR-4432 Targets FGFBP1 in Human Endothelial Cells
105. Editorial: Methods and applications in clinical and translational physiology
106. Choline supplements: An update
107. Editorial: Transcription factors and arrhythmogenesis
108. Linking lifestyle factors to cardiovascular risk through metabolomics: Insights from a large population of diabetic patients followed-up for 11 years
109. COVID-19 Causes Ferroptosis and Oxidative Stress in Human Endothelial Cells
110. Endothelial Dysfunction Drives CRTd Outcome at 1-Year Follow-Up: A Novel Role as Biomarker for miR-130a-5p
111. Influence of Lifestyle Factors in the Management of Diabetes Mellitus
112. Methods and Applications in Clinical and Translational Physiology
113. Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry
114. Therapeutic concordance improves blood pressure control in patients with resistant hypertension
115. Reply to SGLT-2 inhibitors: Post-infarction interventional effects
116. Leaky ryanodine receptors contribute to diaphragmatic weakness during mechanical ventilation
117. Maintenance of normal blood pressure is dependent on IP3R1-mediated regulation of eNOS
118. Diet and Metabolic Dysfunction Volume 2 : Clinical Evidence
119. Endothelial cells: The heart attack of the clones
120. L-Arginine Improves Cognitive Impairment in Hypertensive Frail Older Adults
121. Insulin resistance drives cognitive impairment in hypertensive pre-diabetic frail elders: the CENTENNIAL study.
122. Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools
123. Istaroxime and Beyond: New Therapeutic Strategies to Specifically Activate SERCA and Treat Heart Failure
124. Aprocitentan: New insights
125. Targeting cardiovascular and metabolic disorders through annual nationwide screening and lifestyle intervention: insights from a cohort of 5 819 041 subjects with a 4-year follow-up
126. Efficacy of the New Inotropic Agent Istaroxime in Acute Heart Failure
127. 164 HIGH HDL CHOLESTEROL INCREASES CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS
128. 866 INFARCT SIZE, INFLAMMATORY BURDEN AND ADMISSION HYPERGLYCEMIA IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-INHIBITORS: A MULTICENTER INTERNATIONAL REGISTRY
129. 1134 IN-HOSPITAL ARRHYTHMIC BURDEN REDUCTION IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-INHIBITORS: INSIGHTS FROM THE SGLT2-I AMI PROTECT STUDY
130. 528 OUTCOMES IN DIABETIC PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH SGLT2-I: THE SGLT2-I AMI PROTECT REGISTRY
131. The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension
132. Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA)
133. Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients with Ischemia and Non-Obstructive Coronary Arteries (INOCA)
134. Tirzepatide: A Systematic Update
135. LBODP062 SGLT2 Inhibition Ameliorates Cognitive And Physical Impairment In Patients With HFpEF And Diabetes
136. Beneficial effects of Vitamin C and L-Arginine in the treatment of post-acute sequelae of COVID-19
137. OR24-2 Cutting-edge translational strategies in type 1 diabetes
138. Endothelial dysfunction in long-COVID: New insights from the nationwide multicenter LINCOLN Study
139. Targeting endothelial dysfunction and oxidative stress in Long-COVID
140. Physiology and pathophysiology of excitation–contraction coupling: the functional role of ryanodine receptor
141. Mitochondrial calcium overload is a key determinant in heart failure
142. Genetically enhancing mitochondrial antioxidant activity improves muscle function in aging
143. In permanent AF with narrow QRS, AV junction ablation + CRT vs. rate-control drug therapy reduced mortality
144. Combining L-Arginine with Vitamin C Improves Long-COVID Symptoms: The Nationwide Multicenter LINCOLN Study
145. In-hospital arrhythmic burden reduction in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: Insights from the SGLT2-I AMI PROTECT study
146. Response to Comment on Mone et al. Empagliflozin Improves Cognitive Impairment in Frail Older Adults With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction. Diabetes Care 2022;45:1247–1251
147. miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
148. Abstract P315: Nogo-a Reduces Ceramide De Novo Biosynthesis To Protect From Heart Failure
149. Corrigendum to “Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.”
150. Abstract A1: Sglt2 Inhibition Via Empagliflozin Improves Endothelial Function And Reduces Mitochondrial Oxidative Stress: Insights From Hypertensive And Diabetic Frail Elders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.